The Alpha-1 Foundation's and University of Florida's Alpha-1 Coded Testing (ACT) Study

Description

The Alpha-1 Coded Testing (ACT) Study was established to study genetic testing and outcomes of individuals at risk for alpha-1 antitrypsin deficiency.

Conditions

Alpha-1 Antitrypsin Deficiency

Talk to us

Study Overview

On this page

Study Details

Study overview

The Alpha-1 Coded Testing (ACT) Study was established to study genetic testing and outcomes of individuals at risk for alpha-1 antitrypsin deficiency.

The Alpha-1 Foundation's and University of Florida's Alpha-1 Coded Testing (ACT) Study

The Alpha-1 Foundation's and University of Florida's Alpha-1 Coded Testing (ACT) Study

Condition
Alpha-1 Antitrypsin Deficiency
Intervention / Treatment

-

Contacts and Locations

Gainesville

University of Florida, Gainesville, Florida, United States, 32610

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Individuals of any age at risk for alpha-1 antitrypsin deficiency on the basis of symptoms or family genetic risk.
  • * Any person who has already had genotype and AAT level testing completed and has a qualified result.

Ages Eligible for Study

to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

University of Florida,

Karina Serban, M.D., PRINCIPAL_INVESTIGATOR, University of Florida

Study Record Dates

2050-01